Skip to main content

Table 6 ROC curve for predicting the presence of CSPH in HCV-related liver cirrhosis

From: Impact of sustained virologic response in regression of portal hypertension in Egyptian patients with hepatitis C virus-associated cirrhosis and portal hypertension

Variables

AUC

95% CI

Sig.

Cutoff value

Sensitivity

Specificity

PPV

NPV

Laboratory values

INR

0.633

0.518 to 0.738

0.033

>1.17

87.50%

37.50%

58.3

75

Platelet count

0.887

0.797 to 0.947

< 0.001

≤ 98

82.50%

95%

94.3

84.4

Noninvasive markers

Child-Pugh score

0.897

0.809 to 0.954

< 0.001

> 6

85%

100%

100

87

PC/SD ratio

0.909

0.824 to 0.962

< 0.001

≤ 669

80%

100%

100

83.3

FIB-4 index

0.665

0.551 to 0.767

0.008

> 8.01

47.50%

92.50%

86.4

63.8

King’s score

0.646

0.531 to 0.750

0.022

> 57.95

62.50%

72.50%

69.4

65.9

Lok index

0.637

0.522 to 0.742

0.03

> 2.61

65%

65%

65

65

Portal vein duplex and spleen diameter

PVD

0.949

0.875 to 0.986

< 0.001

> 13.8

82.50%

95%

94.3

84.4

PV velocity

0.984

0.926 to 0.999

< 0.001

≤ 16.5

100%

85%

87

100

Spleen diameter

0.892

0.802 to 0.950

< 0.001

> 14.3

80%

87.50%

86.5

81.4